3SCHOENE R B, HULTGREN H N, SWENSON E R. High-altitude pulmonary edema. In: Hornbein T F, Schoae R B, eds. High-altitude: an exploration of hu- man adaptation[J]. New York: Marcel Dekker, 2001 : 777-814.
5Roach RC, Bartsch P, Hackett PH, et al. The Lake Louise acute mountain sickness scoring system. In: Lake Louise AMS Scoring Committee, eds. Hypoxia and mountain medicine.Burlington VT : Queen City Printers, 1993. 272-274.
6Hackett PH, Robert CR. High-altitude illness. N Engl Med,2001,345 (2) : 107-114.
7Gibbs JS. Pulmonary hemodynamics: implications for high altitude pulmonary edema(HAPE). Adv Exp Med Biol, 1999, 474(8):81-91.
8Baum GL, Wolinsky E. Textbook of pulmonary diseases. 5th ed. Boston:Little Brown,1994. 90-91.
6Murdoch DR.Prevention and treatment of high–altitude illness intravelers[J].Curr Infect Dis Rep,2004,6(1):43-49.
7Razavi IM,Hamilton JA,Feng Q.Modulation of apoptosis by nitricoxide implication in myocardial ischemia and heart failure[J].Pharm Ther,2005,106(2):147-162.
8Furchgott BF,Zawadzri JV.The obligatory role of endothelialcells in the relaxation of arterial smooth muscle by acetylcholione[J].Nature,1980,288(5789):373-376.
9Palmer PM,Ferrige AG,Monlcada S.Nitric oxide release accountsfor the biological activity of endothelium-derived relaxing factor[J].Nature,1987,327(6122):524-526.
